McGuireWoods partner and host Geoff Cockrell invites colleague Amy Cassalia — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of “contingent consideration,” investor risk and buyers’ leverage. Amy explains why she sees high-level use of contingent payments in life sciences deals and why the term “commercially reasonable” often becomes critical when a deal spirals into litigation.
Read the full article: Navigating Nuances of Life Sciences Post-Closing //
Source: https://www.thehealthcareinvestor.com/2026/06/articles/life-sciences-investing/navigating-nuances-of-life-sciences-post-closing-with-amy-cassalia/